Área salud
Efficacy and Safety of Dupilumab for the Treatment of Severe Atopic Dermatitis in Clinical Practice: A Single Center Experience
Background Dupilumab is a new targeted therapy for severe atopic dermatitis (AD) with limited real-world evidence. Objective Explore our experience with dupilumab for AD in clinical practice at a tertiary care center. Material and method […]
Área salud
[Translated article] Spanish Version of the RECAP Questionnaire to Assess Control of Atopic Eczema: Translation, Cultural Adaptation, Validation, and Correlations With Other Patient-Reported Outcome Measures
Background The 7-item RECAP (Recap of Atopic Eczema) questionnaire is used to assess the control of different degrees of eczema severity in patients of all ages. Long-term control of eczema is one of the 4 […]
Área salud
Asma y eczema atópico, determinantes en el riesgo de artrosis
Los fármacos utilizados para amortiguar los impulsos fisiológicos de las reacciones alérgicas en el organismo pueden ayudar a reducir este riesgo.